Chronic Lower Back Pain Trends and Forecast
The future of the global chronic lower back pain market looks promising with opportunities in the hospital pharmacies, retail pharmacies, and online pharmacies markets. The global chronic lower back pain market is expected to grow with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are rising number of instances of strained muscles or ligaments brought on by abrupt movements, heavy lifting, and bad posture, rise in the number of elderly people and an increase in nerve cases globally.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Chronic Lower Back Pain by Segment
The study includes a forecast for the global chronic lower back pain by drug class, route of administration, end-use, and region.
Chronic Lower Back Pain Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:
• Non-Steroidal Anti-Inflammatory Drugs
• Antidepressants
• Analgesics
• Opioids
• Others
Chronic Lower Back Pain Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:
• Oral
• Topical
• Others
Chronic Lower Back Pain Market by End-Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Chronic Lower Back Pain Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Chronic Lower Back Pain Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chronic lower back pain companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chronic lower back pain companies profiled in this report include-
• Johnson & Johnson Services
• Pfizer
• Vertebral Technologies
• Merck & Co.
• Medtronic
• Boston Scientific
• Mesoblast
• SpineThera
• Stayble Therapeutics
• Eli Lilly & Company
Chronic Lower Back Pain Market Insights
Lucintel forecasts that analgesic is expected to witness the highest growth over the forecast period.
Within this market, hospital pharmacy is expected to witness the highest growth.
North America is expected to witness highest growth over the forecast period because the pharma companies are concentrating on the research and development of cutting-edge pharmaceuticals due to the necessity for progressive therapy.
Features of the Global Chronic Lower Back Pain Market
Market Size Estimates: Chronic lower back pain market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Chronic lower back pain market size by drug class, route of administration, end-use, and region in terms of value ($B).
Regional Analysis: Chronic lower back pain market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different drug class, route of administration, end-use, and regions for the chronic lower back pain market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chronic lower back pain market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for chronic lower back pain market?
Answer: The global chronic lower back pain market is expected to grow with a CAGR of 6.5% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the chronic lower back pain market?
Answer: The major drivers for this market are rising number of instances of strained muscles or ligaments brought on by abrupt movements, heavy lifting, and bad posture, rise in the number of elderly people and an increase in nerve cases globally.
Q3. What are the major segments for chronic lower back pain market?
Answer: The future of the global chronic lower back pain market looks promising with opportunities in the hospital pharmacies, retail pharmacies, and online pharmacies markets.
Q4. Who are the key chronic lower back pain market companies?
Answer: Some of the key chronic lower back pain companies are as follows:
• Johnson & Johnson Services
• Pfizer
• Vertebral Technologies
• Merck & Co.
• Medtronic
• Boston Scientific
• Mesoblast
• SpineThera
• Stayble Therapeutics
• Eli Lilly & Company
Q5. Which chronic lower back pain market segment will be the largest in future?
Answer: Lucintel forecasts that analgesic is expected to witness the highest growth over the forecast period.
Q6. In chronic lower back pain market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period because the pharma companies are concentrating on the research and development of cutting-edge pharmaceuticals due to the necessity for progressive therapy.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the chronic lower back pain market by drug class (non-steroidal anti-inflammatory drugs, antidepressants, analgesics, opioids, and others), route of administration (oral, topical, and others), end-use (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Chronic Lower Back Pain Market, Chronic Lower Back Pain Market Size, Chronic Lower Back Pain Market Growth, Chronic Lower Back Pain Market Analysis, Chronic Lower Back Pain Market Report, Chronic Lower Back Pain Market Share, Chronic Lower Back Pain Market Trends, Chronic Lower Back Pain Market Forecast, Chronic Lower Back Pain Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.